Creat­ing the Future
Projects

Electrophilic Reactiv­ity Provid­ing Well-Defined Helically Chiral Gold(III) Catalysts for the Asymmet­ric Synthe­sis of Bioac­tive Compounds

Hanock Baiju - Hector RCD Awardee Agnieszka Nowak-Król
Hector Fellow A. Stephen K. Hashmi

The aim of the project led by Hector RCD Awardee Agnieszka Nowak-Król (University of Würzburg) and Hector Fellow A. Stephen K. Hashmi (Heidelberg University) is to develop well-defined helically chiral gold(III) complexes, the first examples of helically chiral gold complexes with gold atoms on either an outer or an inner helicene rim. The catalytic potential of these unprecedented complexes and their practical utility will be demonstrated in the enantioselective synthesis of small organic compounds and biologically or pharmaceutically relevant targets, i.e. natural products and pharmaceutically active compounds.

© kitipol - Adobe Stock

Repre­sen­ta­tion Learn­ing and Causal­ity: Theory, Practice, and Impli­ca­tions for Mecha­nis­tic Interpretability

Florent Draye - Hector Fellow Bernhard Schölkopf

This research projec aims to contribute to the development of methods that extract informative and interpretable features from high-dimensional datasets, with a focus on uncovering high-level causally related factors that describe meaningful semantics of the data. This, in turn, can help us gain deeper insights into the representations found within advanced generative models, particularly foundation models and LLMs, with the goal of improving their efficiency and safety.

Representation Learning and Causality: Theory, Practice, and Implications for Mechanistic Interpretability© Florent Draye

Inducible CRISPR gene editing systems for patho­genic USH2A variants

Salome Spaag - Hector Fellow Eberhart Zrenner

Amongst the leading causes of retinal dystrophies worldwide is Retinitis pigmentosa, a severe disease often caused by splice variants in the USH2A gene. This project aims to develop a safe CRISPR-based therapeutic strategy for correction of such splicing defects. Using enhanced-deletion nucleases, the disease-causing alterations can be eliminated, hereby restoring correct protein synthesis. The focus lies on safety features as well as the development of an inducible viral delivery system for clinical application.

Inducible CRISPR gene editing systems for pathogenic USH2A variants© Salome Spaag